Related Articles
Amplification of the NSD3‑BRD4‑CHD8 pathway in pelvic high‑grade serous carcinomas of tubo‑ovarian and endometrial origin
Genome‑wide analysis of gynecologic cancer: The Cancer Genome Atlas in ovarian and endometrial cancer (Review)
Gene amplification of chromatin remodeling factor <em>SMARCC2</em> and low protein expression of ACTL6A are unfavorable factors in ovarian high‑grade serous carcinoma
Validity of an NGS‑based multiple gene panel in identifying actionable mutations for patients with NSCLC in a Chinese hospital
Advances in predicting breast cancer driver mutations: Tools for precision oncology (Review)